Second primary lung cancer after head and neck squamous cell cancer: Population-based study of risk factors

Head and Neck

Volumn 34, Issue 12, 2012, Pages 1782-1788

  Milano, Michael T ^a   Peterson III, Carl R ^a   Zhang, Hong ^a   Singh, Deepinder P ^a   Chen, Yuhchyau ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

cancer survivorship; head and neck cancer; non small cell lung cancer; population based; squamous cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RISK; CLINICAL FEATURE; DEMOGRAPHY; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SECOND CANCER;

ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS, SECOND PRIMARY; RISK FACTORS; SEER PROGRAM; SEX FACTORS; UNITED STATES;

EID: 84869500562     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.22006     Document Type: Article

References (47)

1. Leõn X, Ferlito A, Myer CM III, et al. Second primary tumors in head and neck cancer patients Acta Otolaryngol 2002; 122: 765-778.
2. Cooper JS, Pajak TF, Rubin P, et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience Int J Radiat Oncol Biol Phys 1989; 17: 449-456.
3. Boice JD Jr, Storm HH, Curtis RE, et al. Introduction to the study of multiple primary cancers. Natl Cancer Inst Monogr 1985; 68: 3-9.
4. Travis LB,. The epidemiology of second primary cancers. Cancer Epidemiol Biomarkers Prev 2006; 15: 2020-2026.
5. Leon X, Quer M, Diez S, Orus C, Lopez-Pousa A, Burgues J,. Second neoplasm in patients with head and neck cancer. Head Neck 1999; 21: 204-210.
6. Leon X, Quer M, Diez S, Orus C, Lopez-Pousa A, Burgues J,. Second neoplasm in patients with head and neck cancer Head Neck 1999; 21: 204-210.
7. McDonald S, Haie C, Rubin P, Nelson D, Divers LD,. Second malignant tumors in patients with laryngeal carcinoma: diagnosis, treatment, and prevention. Int J Radiat Oncol Biol Phys 1989; 17: 457-465.
8. Chuang SC, Scelo G, Tonita JM, et al. Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries Int J Cancer 2008; 123: 2390-2396.
9. Ha PK, Califano JA,. The molecular biology of mucosal field cancerization of the head and neck. Crit Rev Oral Biol Med 2003; 14: 363-369.
10. Licciardello JT, Spitz MR, Hong WK,. Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung. Int J Radiat Oncol Biol Phys 1989; 17: 467-476.
11. Duchateau CS, Stokkel MP,. Second primary tumors involving non-small cell lung cancer: prevalence and its influence on survival. Chest 2005; 127: 1152-1158.
12. Ritoe SC, Krabbe PF, Jansen MM, et al. Screening for second primary lung cancer after treatment of laryngeal cancer. Laryngoscope 2002; 112: 2002-2008.
13. Morris LG, Sikora AG, Patel SG, Hayes RB, Ganly I,. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J Clin Oncol 2011; 29: 739-746.
14. Deleyiannis FW, Thomas DB,. Risk of lung cancer among patients with head and neck cancer. Otolaryngol Head Neck Surg 1997; 116: 630-636.
15. Curtis RE, Freedman DM, Ron Elaine, et al, editors. New malignancies among cancer survivors: SEER cancer registries, 1973-2000. Bethesda, Maryland: National Cancer Institute; 2006.
16. Goggins WB, Yu IT, Tse LA, Leung SF, Tung SY, Yu KS,. Risk of second primary malignancies following nasopharyngeal carcinoma in Hong Kong. Cancer Causes Control 2010; 21: 1461-1466.
17. Nakamizo M, Kamata S, Kawabata K, et al. Multiple primary cancers in patients with head and neck cancer and history of tobacco smoking and drinking. [Article in Japanese] Nippon Jibiinkoka Gakkai Kaiho 1993; 96: 1501-1509.
18. Moolgavkar SH, Dewanji A, Luebeck G,. Cigarette smoking and lung cancer: reanalysis of the British doctors' data. J Natl Cancer Inst 1989; 81: 415-420.
19. Silverman S Jr, Gorsky M, Greenspan D,. Tobacco usage in patients with head and neck carcinomas: a follow-up study on habit changes and second primary oral/oropharyngeal cancers. J Am Dent Assoc 1983; 106: 33-35.
20. Hiyama T, Sato T, Yoshino K, Tsukuma H, Hanai A, Fujimoto I,. Second primary cancer following laryngeal cancer with special reference to smoking habits. Jpn J Cancer Res 1992; 83: 334-339.
21. Chung CH, Gillison ML,. Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res 2009; 15: 6758-6762.
22. Haraf DJ, Nodzenski E, Brachman D, et al. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res 1996; 2: 755-762.
23. Sturgis EM, Cinciripini PM,. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 2007; 110: 1429-1435.
24. Chen MC, Chen PT, Chan CH, et al. Second primary esophageal or lung cancer in patients with head and neck carcinoma in Taiwan: incidence and risk in relation to primary index tumor site. J Cancer Res Clin Oncol 2010; 137: 115-123.
25. Geurts TW, Nederlof PM, van den Brekel MW, et al. Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary? Clin Cancer Res 2005; 11: 6608-6614.
26. Kuriakose MA, Loree TR, Rubenfeld A, et al. Simultaneously presenting head and neck and lung cancer: a diagnostic and treatment dilemma. Laryngoscope 2002; 112: 120-123.
27. Leong PP, Rezai B, Koch WM, et al. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst 1998; 90: 972-977.
28. Yamamoto E, Shibuya H, Yoshimura R, Miura M,. Site specific dependency of second primary cancer in early stage head and neck squamous cell carcinoma. Cancer 2002; 94: 2007-2014.
29. Loh KS, Brown DH, Baker JT, Gilbert RW, Gullane PJ, Irish JC,. A rational approach to pulmonary screening in newly diagnosed head and neck cancer. Head Neck 2005; 27: 990-994.
30. van Oijen MG, Leppers Vd Straat FG, Tilanus MG, Slootweg PJ,. The origins of multiple squamous cell carcinomas in the aerodigestive tract. Cancer 2000; 88: 884-893.
31. Braakhuis BJ, Tabor MP, Leemans CR, van der Waal I, Snow GB, Brakenhoff RH,. Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck 2002; 24: 198-206.
32. Chung KY, Mukhopadhyay T, Kim J, et al. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 1993; 53: 1676-1683.
33. Giefing M, Rydzanicz M, Szukala K, et al. Second primary tumors (SPT) of head and neck: distinguishing of "true" SPT from micrometastasis by LOH analysis of selected chromosome regions. Neoplasma 2005; 52: 374-380.
34. Leong PP, Rezai B, Koch WM, et al. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst 1998; 90: 972-977.
35. Harari PM,. Re: Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst 1998; 90: 1571.
36. Jemal A, Siegel R, Xu J, Ward E,. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
37. Sant M, Aareleid T, Berrino F, et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary. Ann Oncol 2003; 14 Suppl 5: v61-118.
38. Berrino F, Gatta G,. Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. Eur J Cancer 1998; 34: 2154-2161.
39. Panosetti E, Luboinski B, Mamelle G, Richard JM,. Multiple synchronous and metachronous cancers of the upper aerodigestive tract: a nine-year study. Laryngoscope 1989; 99: 1267-1273.
40. Cooper JS, Pajak TF, Rubin P, et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 1989; 17: 449-456.
41. Jemal A, Ward E, Thun M,. Declining death rates reflect progress against cancer. PLoS One 2010; 5: e9584.
42. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 2004; 101: 3-27.
43. Quadrelli S, Lyons G, Colt H, Chimondeguy D, Silva C,. Lung cancer as a second primary malignancy: increasing prevalence and its influence on survival. Ann Surg Oncol 2009; 16: 1033-1038.
44. Cataldo JK, Dubey S, Prochaska JJ,. Smoking cessation: an integral part of lung cancer treatment. Oncology 2010; 78: 289-301.
45. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst 2010; 102: 1771-1779.
46. National Lung Screening Trial Research Team, Aberle DR, Berg CD, et al. The National Lung Screening Trial: overview and study design. Radiology 2011; 258: 243-253.
47. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365: 395-409.